8-KItem 2.02 · Results of OperationsItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
GE HealthCare reports Q3 growth and raises 2026 guidance
Filed with the SEC on · Summarized by InvestorsBot
GE HealthCare reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year over year, with diluted EPS of $1.36 and adjusted EPS of $1.34; the quarter ended September 30 and results were released October 28. The company raised its full-year outlook to approximately 4% organic revenue growth, adjusted EPS of $4.95-$5.05, and free cash flow of at least $1.6 billion, while also announcing plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027.